NCT06469866

Brief Summary

BACKGROUND: Some studies have revealed that deep neuromuscular block (NMB) improve surgical conditions and alleviated postoperative pain compared with moderate NMB. The present study investigated deep NMB could improve the quality of recovery after laparoscopic hysterectomy METHODS: seventy-two women with elective laparoscopic hysterectomy were randomly divided into 2 groups: Patients in group A received low-pressure pneumoperitoneum (LPP), which was set at 8-10 mmHg with deep NMB. Patients in group B received standard-pressure pneumoperitoneum (SPP), which was set at 12-14 mmHg with moderate NMB. Primary outcome was the quality of recovery (QoR-15) at 1 day after sugery. The secondary outcomes included postoperative pain, surgical condition, incidence of shoulder pain, the incidence of rescue analgesic drug use, cumulative dose of analgesics, time of first flatus, post-operative nausea and vomiting, time of tracheal tube removal.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

June 25, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2024

Completed
Last Updated

June 24, 2024

Status Verified

June 1, 2024

Enrollment Period

5 months

First QC Date

June 11, 2024

Last Update Submit

June 19, 2024

Conditions

Keywords

Neuromuscular blockRecoveryLaparoscopic hysterectomy

Outcome Measures

Primary Outcomes (1)

  • Quality of recovery

    Primary outcome measure was the quality of recovery at 1 day after surgery. Quality of recovery-15 scale was used to assess the quality of recovery after operation. A higher score of quality of recovery-15 scale indicates a better quality of recovery after surgery

    1 day after operation

Secondary Outcomes (2)

  • Shoulder pain

    The first 24 hours after operation

  • Postoperative nausea and vomiting

    The first 24 hours after operation

Study Arms (2)

low-pressure pneumoperitoneum (LPP) with deep NMB affect quality of recovery

EXPERIMENTAL

low-pressure pneumoperitoneum (LPP) with deep NMB.

Device: low-pressure pneumoperitoneumDevice: standard-pressure pneumoperitoneum

standard-pressure pneumoperitoneum (SPP) with moderate NMB affect quality of recovery

EXPERIMENTAL

standard-pressure pneumoperitoneum (SPP) with moderate NMB.

Device: low-pressure pneumoperitoneumDevice: standard-pressure pneumoperitoneum

Interventions

low-pressure pneumoperitoneum (LPP) with deep NMB.

low-pressure pneumoperitoneum (LPP) with deep NMB affect quality of recoverystandard-pressure pneumoperitoneum (SPP) with moderate NMB affect quality of recovery

standard-pressure pneumoperitoneum (SPP) with moderate NMB.

low-pressure pneumoperitoneum (LPP) with deep NMB affect quality of recoverystandard-pressure pneumoperitoneum (SPP) with moderate NMB affect quality of recovery

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status Ⅰ- Ⅲ
  • Scheduled for elective laparoscopic hysterectomy

You may not qualify if:

  • Inability to give informed consent
  • BMI \>35
  • Renal or hepatic insufficiency
  • History of preoperative psychiatric
  • Previous surgery at procedure site
  • Neuromuscular disease, pregnancy, and contraindications to study medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anqing Munucipal Hospital Anesthesiology

Anqing, Anhui, 246000, China

RECRUITING

Central Study Contacts

Xu si qi, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2024

First Posted

June 24, 2024

Study Start

June 25, 2024

Primary Completion

November 25, 2024

Study Completion

November 25, 2024

Last Updated

June 24, 2024

Record last verified: 2024-06

Locations